7650nok
-4,0 %
Date:2025-08-01Time:18:00:00Latest report:Q2-2025List:Oslo BorsTicker:AKBM
Market Cap:6 709 mnokEnterprise Value:8 358 mnokNet Sales:207,3 musdEarnings:-25,0 musdEmployees:0ISIN:NO0010886625
Ratios
10-year key figure history for Aker BioMarine turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Aker BioMarine with index and moving average MA50 and MA200.
Stockprice:76,50
MA50:66,29
MA200:60,77
Price/MA200:25,9 %
RSI (14):59,1
Price/MA50:15,4 %
Description
Aker BioMarine operates in biotechnology. The company specializes in the development of dietary supplements. The product portfolio is broad and includes, for example, omega-3 oil, nutritional supplements for animals, and protein supplements for fish farming. The business is operated globally with the largest presence in the Nordic market. Customers consist of both private players and wholesalers. Aker BioMarine was founded in 2006 and is headquartered in Oslo.